Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04095663 · ClinicalTrials.gov registry record · NA
Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial
A NA study of Diverticulitis, sponsored by University of Washington.
- Active
- Registry status
- NA
- Development phase
- 255
- Enrollment target
- 20
- Study locations
NCT04095663 is a NA study of Diverticulitis that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 255 participants, below the 25,204-participant average among 8 other Diverticulitis trials with a reported enrollment target (99% lower). The trial reports 20 study locations across 10 states.
The verdict
NCT04095663, a NA study of Diverticulitis, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 255 participants
- Enrollment target
- 20
- Study locations
Study Summary
The COSMID (Comparison of Surgery and Medicine on the Impact of Diverticulitis) trial is a pragmatic, patient-level randomized superiority trial of elective colectomy vs. best medical management for patients with quality of life (QoL) limiting diverticular disease. A parallel observational cohort will include those who are disinclined to have their treatment choice randomized, but are willing to contribute information about their outcomes. The goal of the COSMID trial is to answer the question: For patients with QoL-limiting diverticular disease, is elective colectomy more effective than best medical management? The hypothesis being tested in the COSMID trial is that patient-reported outcomes (PROs) among patients in the surgery arm will be superior to those in the best medical management arm.
Conditions Studied
Interventions
- OTHER Medical Management
- PROCEDURE Partial Colectomy
Study Locations (20)
New York
- Albany Medical College - Albany
- New York Presbyterian-Queens - Flushing
- Columbia University Medical Center - New York
- Weill Cornell Medicine - New York
- University of Rochester Medical Center - Rochester
California
- Cedars-Sinai Medical Center - Los Angeles
- UC San Diego Health - San Diego
- UCSF Health - San Francisco
- Stanford University Medical Center - Stanford
Florida
- University of Florida - Gainesville
- University of South Florida - Tampa
Illinois
- Rush University Medical Center - Chicago
- Northwestern University - Evanston
Massachusetts
- Boston University Medical Center - Boston
- Lahey Clinic - Burlington
Colorado
- University of Colorado - Denver
Georgia
- Memorial Health University Medical Center - Savannah
Iowa
- University of Iowa Healthcare - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04095663
The ClinicalTrials.gov registry entry for NCT04095663 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 25,204-participant average among 8 other Diverticulitis trials with a reported enrollment target (99% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diverticulitis appearing as the primary indexed condition, and to 2 interventions - of which Medical Management is the first listed.
NCT04095663 reports 20 study locations spanning 10 distinct geographic areas - top geographies include New York, California, Florida.
Frequently Asked Questions
What is clinical trial NCT04095663 about?
NCT04095663 is a clinical study titled "Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial". The COSMID (Comparison of Surgery and Medicine on the Impact of Diverticulitis) trial is a pragmatic, patient-level randomized superiority trial of elective colectomy vs. best medical management for patients with quality of life (QoL) limiting diverticular disease. A parallel observational cohort wi...
What is the current status of trial NCT04095663?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 255 participants. The study started on 2019-10-01. Estimated completion is 2027-02-01.
What conditions does trial NCT04095663 study?
This clinical trial studies the following conditions: Diverticulitis.
What interventions are being tested in trial NCT04095663?
The interventions under investigation include: Medical Management (OTHER), Partial Colectomy (PROCEDURE).
Who is sponsoring clinical trial NCT04095663?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04095663 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diverticulitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigation of Medical Management to Prevent Episodes of Diverticulitis Trial
ACTIVE NOT RECRUITING · NA
-
Effect of Gum Arabic on Gastrointestinal Transit and Permeability
COMPLETED · NA
-
FMT in Uncomplicated Diverticulitis
ACTIVE NOT RECRUITING · Early Phase 1
-
Early Post-Op Recovery After Partial Large Bowel Resection
COMPLETED
-
Prevention of Recurrence of Diverticulitis
COMPLETED · Phase 3
-
General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.